Home › NDC Lookup › RxCUI directory › RxCUI 1244634

Betamethasone valerate 1.2 MG/ML Topical Foam — RxCUI 1244634

RxNorm drug concept · Semantic clinical drug
RxCUI 1244634 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1244634
Official nameBetamethasone valerate 1.2 MG/ML Topical Foam
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbetamethasone valerate 0.12 % Topical Foam
FDA products mapped5
Package NDCs mapped10
Reported Medicaid activity (SDUD)627 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Betamethasone Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Betamethasone topical is used for skin conditions that respond to steroid treatment — things like psoriasis, eczema, and other inflammatory skin problems that cause redness and itc...
  • What skin conditions does betamethasone topical treat?
  • Apply a small amount — a thin layer or just a few drops — directly to the affected area once or twice daily, depending on which product you have. Rub it in gently until it disappea...
  • These products are meant for short-term use. In general, you should see improvement within two weeks — if you don't, check back with your doctor rather than continuing on your own....
📖 Read our full Betamethasone Topical guide →

🕸️ Concept Web — How Betamethasone valerate 1.2 MG/ML Topical Foam Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Betamethasone valerate 1.2 MG/ML Topical Foam RxCUI 1244634

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Betamethasone 1514
    • Betamethasone valerate 227897
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Luxiq 261566
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Betamethasone Topical Foam 384499
    • Betamethasone valerate Topical Foam 2648726
    • Betamethasone Topical Product 1153804
    • Betamethasone valerate Topical Product 2659633
    • Betamethasone Topical Foam [Luxiq] 384500
    • Betamethasone valerate Topical Foam [Luxiq] 2656376
    • Luxiq Topical Product 1182068
    • Topical Foam 346285
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Betamethasone valerate 1.2 MG/ML 1244633
    • Betamethasone valerate 1.2 MG/ML Topical Foam [Luxiq] 1244636
    • Betamethasone valerate 1.2 MG/ML [Luxiq] 1244635

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Betamethasone valerate 1.2 MG/ML SCDC · 1244633
  • Betamethasone Topical Foam SCDF · 384499
  • Betamethasone valerate Topical Foam SCDFP · 2648726
  • Betamethasone Topical Product SCDG · 1153804
  • Betamethasone valerate Topical Product SCDGP · 2659633

Brand-Name Concepts

  • Betamethasone valerate 1.2 MG/ML Topical Foam [Luxiq] SBD · 1244636
  • Betamethasone valerate 1.2 MG/ML [Luxiq] SBDC · 1244635
  • Betamethasone Topical Foam [Luxiq] SBDF · 384500
  • Betamethasone valerate Topical Foam [Luxiq] SBDFP · 2656376
  • Luxiq Topical Product SBDG · 1182068
  • Luxiq BN · 261566

📦 FDA Products & Package NDCs

5 products · 10 package NDCs
10 package NDCs map to RxCUI 1244634 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
45802-0053-01 1 CAN in 1 CARTON (45802-053-01) / 50 g in 1 CAN Betamethasone Valerate Padagis Israel Pharmaceuticals Ltd 2013-01-15
45802-0053-02 1 CAN in 1 CARTON (45802-053-02) / 100 g in 1 CAN Betamethasone Valerate Padagis Israel Pharmaceuticals Ltd 2013-01-15
46708-0708-31 1 CAN in 1 CARTON (46708-708-31) / 100 g in 1 CAN Betamethasone valerate Alembic Pharmaceuticals Limited 2024-08-22
46708-0708-50 1 CAN in 1 CARTON (46708-708-50) / 50 g in 1 CAN Betamethasone valerate Alembic Pharmaceuticals Limited 2024-08-22
51672-4188-03 1 CAN in 1 CARTON (51672-4188-3) / 50 g in 1 CAN Betamethasone Valerate Sun Pharmaceutical Industries, Inc. 2017-05-24
51672-4188-07 1 CAN in 1 CARTON (51672-4188-7) / 100 g in 1 CAN Betamethasone Valerate Sun Pharmaceutical Industries, Inc. 2017-05-24
62332-0708-31 1 CAN in 1 CARTON (62332-708-31) / 100 g in 1 CAN Betamethasone valerate Alembic Pharmaceuticals Inc. 2024-08-22
62332-0708-50 1 CAN in 1 CARTON (62332-708-50) / 50 g in 1 CAN Betamethasone valerate Alembic Pharmaceuticals Inc. 2024-08-22
70700-0141-19 1 CANISTER in 1 CARTON (70700-141-19) / 50 g in 1 CANISTER Betamethasone Valerate Xiromed, LLC. 2023-05-10
70700-0141-20 1 CANISTER in 1 CARTON (70700-141-20) / 100 g in 1 CANISTER Betamethasone Valerate Xiromed, LLC. 2023-05-10
Observed labelers: Alembic Pharmaceuticals Inc. (2) · Alembic Pharmaceuticals Limited (2) · Padagis Israel Pharmaceuticals Ltd (2) · Sun Pharmaceutical Industries, Inc. (2) · Xiromed, LLC. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$0.7210
Range $0.6699–$0.7721 · middle 50% $0.6699–$0.7721 · 8 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.